Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
N/A N=108 Randomized Double-blind Basic Science

Behavioral Differences in Effortful Control

Healthy

Bottom Line

View on ClinicalTrials.gov: NCT01852344 ↗
Enrolled (actual)
108
Serious AEs
0.0%
Results posted
Jan 2018
Primary outcome: Primary: Reaction Time on the Multi-Source Interference Task — 300; 330; 310; 280 milliseconds — p=0.159

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Methylphenidate (Drug); Placebo (Drug); Easy Behavioral Task (Behavioral); Hard Behavioral Task (Behavioral)
Age
Adult · 18+ yrs
Sex
All
Sponsor
University of Michigan
Primary completion
Jun 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Reaction Time on the Multi-Source Interference Task		 300; 330; 310; 280 0.159
SECONDARY
Accuracy on the Multi-Source Interference Task.		 94.1; 94.3; 96.1; 96.6 0.236
SECONDARY
Reaction Time Variability on the Multi-Source Interference Task.		 270; 320; 270; 260 0.032 sig

Summary

Effortful control refers to the mental processes that help a person to regulate his or her own attention, thoughts, and emotions. This study will examine behavioral differences in healthy individuals when performing a task that induces fatigue. The purpose of this study is to examine the effects of methylphenidate on the cognitive functions in healthy individuals when performing fatiguing cognitive tasks.

Eligibility Criteria

Inclusion Criteria

  • Age range 18-35

Exclusion Criteria

  • Pregnant or nursing (females)
  • Any clinically significant medical condition
  • Currently taking any medications (i.e., decongestants)
  • Currently taking any psychoactive medications
  • Alcohol or substance abuse (current or in the past 2 years)
  • Liver or Kidney disease
  • Any clinically significant personal or family history of cardiac problems
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01852344). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search